Delivery Order SPE2DB22D2206-SPE2DB25FHL77
Award Date 6/16/25
Potential Completion Date 7/9/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Lynparza 150 mg tablets (120-count units) valued at $10,567.60, with completion expected by July 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $52,598.10 for the supply of Lynparza 100 mg tablets (120-count units) on September 4, 2025, with an ultimate completion date of September 25, 2025. The contract carries no set-aside designation and was competitively awarded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical procurement for military and federal healthcare systems. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,543.70 for 60 tablets of Lynparza 100 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,249.67 to supply Lynparza 150 mg tablets (60-count units) under a firm fixed-price contract. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate headquarters and primary...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lynparza 100 mg tablets (120-count units). This competitively awarded, firm fixed-price delivery order has a ceiling value of approximately $21,039 and is scheduled for completion by August 18, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement. The contract was awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Lynparza 100 mg tablets (120 count) with a ceiling value of $21,039.24. This firm fixed-price delivery order, which must be completed by July 17, 2025, represents a non-competitive, competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60 units. This delivery order, valued at $10,499.34 under a firm fixed-price contract type, represents a non-competitive procurement and is scheduled for completion by October 7, 2025. The award was issued to AmerisourceBergen's Corporate Office division, with performance occurring at the company's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $10,499.34 to AmerisourceBergen Drug Corp for 60 tablets of LYNPARZA 150 mg, a pharmaceutical product for oncology treatment. The contract, awarded on August 19, 2025, with an ultimate completion date of September 10, 2025, carries firm fixed pricing and represents a non-set-aside competitive award. Performance will be executed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lynparza 150 mg tablets (120-count units) with a firm fixed price ceiling value of $21,135.20 and ultimate completion date of September 10, 2025. This delivery order represents a non-competitive award and is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...